IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 201–300 of 839
Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., Winum, J.-Y., Lambin, P., Dubois, L., Pavathaneni, N.-K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4498 · Cited by 96
Cytokine disbalance in common human cancers
Čulig, Z. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.010 · Cited by 103
Saidi, A., Hagedorn, M., Allain, N., Verpelli, C., Sala, C., Bello, L., Bikfalvi, A., & Javerzat, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24380 · Cited by 95
Li, J., Lan, T., Zhang, C., Zeng, C., Hou, J., Yang, Z., Zhang, M., Liu, J., & Liu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.2671 · Cited by 101
Cioce, M., Gherardi, S., Viglietto, G., Strano, S., Blandino, G., Muti, P., & Ciliberto, G. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12371 · Cited by 94
Tumor-Initiating and -Propagating Cells: Cells That We Would to Identify and Control
Tysnes, B. B. (2010) · Neoplasia · doi:10.1593/neo.10290 · Cited by 100
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
Hsu, H., Lin, J.-H., Hsu, T.-W., Su, K., Wang, C.-W., Yang, K., Chiou, S., & Hung, S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.07.001 · Cited by 99
Obesity and Cancer Metastasis: Molecular and Translational Perspectives
Annett, S., Moore, G., & Robson, T. (2020) · Cancers · doi:10.3390/cancers12123798 · Cited by 100
Notch3: from subtle structural differences to functional diversity
Bellavia, D., Checquolo, S., Campese, A. F., Felli, M. P., Gulino, A., & Screpanti, I. (2008) · Oncogene · doi:10.1038/onc.2008.230 · Cited by 99
Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue
Casbas-Hernández, P., Sun, X., Romàn-Pèrez, E., D’Arcy, M. E., Sandhu, R., Hishida, A., McNaughton, K. K., Yang, X. R., Makowski, L., Sherman, M. E., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0934 · Cited by 99
TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
Shields, B. J., Wiede, F., Gurzov, E. N., Wee, K., Hauser, C., Zhu, H.-J., Molloy, T. J., O'Toole, S. A., Daly, R. J., Sutherland, R. L., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01016-12 · Cited by 93
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53
Salvioli, S., Capri, M., Bucci, L., Lanni, C., Racchi, M., Uberti, D. L., Memo, M., Mari, D., Govoni, S. M., & Franceschi, C. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0639-6 · Cited by 100
Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
Zhang, C. C., Yan, Z., Zong, Q., Fang, D. D., Painter, C., Zhang, Q., Chen, E., Lira, M. E., John-Baptiste, A., & Christensen, J. G. (2013) · STEM CELLS Translational Medicine · doi:10.5966/sctm.2012-0096 · Cited by 94
Aburjania, Z., Jang, S., Whitt, J. D., Jaskula-Stzul, R., Chen, H., & Rose, J. B. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0677 · Cited by 98
Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk
Chen, H., Liu, D., Yang, Z., Sun, L., Deng, Q., Yang, S., Qian, L., Guo, L., Yu, M., Hu, M., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0236 · Cited by 86
Kim, G., Ouzounova, M., Quraishi, A. A., Davis, A., Tawakkol, N., Clouthier, S. G., Malik, F. A., Paulson, A. K., D'Angelo, R. C., Korkaya, S., et al. (2014) · Oncogene · doi:10.1038/onc.2014.4 · Cited by 98
Notch3 signalling promotes tumour growth in colorectal cancer
Serafin, V., Persano, L., Moserle, L., Esposito, G., Ghisi, M., Curtarello, M., Bonanno, L., Masiero, M., Ribatti, D., Stürzl, M., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2895 · Cited by 99
Prattichizzo, F., Giuliani, A., Recchioni, R., Bonafè, M., Marcheselli, F., De Carolis, S., Campanati, A., Giuliodori, K., Rippo, M. R., Brugè, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7858 · Cited by 90
Self-citationDynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
Semenza, G. L. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.09.004 · Cited by 97
Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop
Ling, C., Min, L., Wang, X. J., Zhao, J., Chen, H., Qin, J., Chen, W., Shen, Z., Tang, Z., Gan, Q., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3690 · Cited by 97
Notch signalling in cancer progression and bone metastasis
Sethi, N. S., & Kang, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.497 · Cited by 97
Hendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594044 · Cited by 96
Coupland, K., Lendahl, U., & Karlström, H. (2018) · Stroke · doi:10.1161/strokeaha.118.021560 · Cited by 95
Lü, J., Xu, B., Zheng, Z., Xie, J., Wang, J.-B., Lin, J., Chen, Q., Cao, L., Lin, M., Tu, R., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0892-0 · Cited by 95
STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
To, S. Q., Dmello, R. S., Richards, A. K., Ernst, M., & Chand, A. L. (2022) · Cancers · doi:10.3390/cancers14020429 · Cited by 86
Liang, Z., Wu, G., Fan, C., Xu, J., Jiang, S., Yan, X., Di, S., Ma, Z., Hu, W., & Yang, Y. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.11.001 · Cited by 95
Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy
Khazali, A. S., Clark, A. M., & Wells, A. H. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.414 · Cited by 95
Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ho, L., Luo, S., & Lai, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.009 · Cited by 94
Markopoulos, G. S., Roupakia, E., Marcu, K. B., & Kolettas, E. (2019) · Cells · doi:10.3390/cells8101143 · Cited by 81
Self-citationDeterminants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Pavlopoulou, A., Oktay, Y., Vougas, K. N., Louka, M. A., Vorgias, C. E., & Georgakilas, A. G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.018 · Cited by 94
Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis
Fazio, C., & Ricciardiello, L. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.408 · Cited by 93
Cancer stem cells: Models, mechanisms and implications for improved treatment
Zhou, J., & Zhang, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5953 · Cited by 92
Protein Kinase Cζ Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo
Galvez, A. S., Durán, Á., Linares, J. F., Pathrose, P., Castilla, E. A., Abu‐Baker, S., Leitges, M., Díaz-Meco, M. T., & Moscat, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01294-08 · Cited by 91
Breast Cancer Associated Metastasis is Significantly Increased in a Model of Autoimmune ArthritisPreprint
Roy, L. D., Pathangey, L. B., Tinder, T. L., Schettini, J. L., Gruber, H. E., & Mukherjee, P. (2008) · Nature Precedings · doi:10.1038/npre.2008.2632.1 · Cited by 91
Notch Signaling and Breast Cancer
Reedijk, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_18 · Cited by 90
Drug resistance in breast cancer: Mechanisms and strategies for management
Wu, G., Xiao, M., Hao, W.-C., Yang, Z., Liu, X., Xu, D., Peng, Z.-X., & Zhang, L. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101288 · Cited by 90
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
Sheshadri, N., Catanzaro, J. M., Bott, A. J., Sun, Y., Ullman, E., Chen, E. I., Pan, J.-A., Wu, S., Crawford, H. C., Zhang, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0798 · Cited by 89
Leslie, K., Gao, S. P., Berishaj, M., Podsypanina, K., Ho, H., Ivashkiv, L., & Bromberg, J. (2010) · Breast Cancer Research · doi:10.1186/bcr2725 · Cited by 81
Salivary Levels of TNF-α and IL-6 in Patients with Oral Premalignant and Malignant Lesions
Juretić, M., Cerović, R., Belušić-Gobić, M., Pršo, I. B., Kqiku, L., Špalj, S., & Pezelj‐Ribarić, S. (2013) · Folia Biologica · doi:10.14712/fb2013059020099 · Cited by 88
Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells
Hernández‐Vargas, H., Ouzounova, M., Calvez‐Kelm, F. L., Lambert, M.-P., McKay‐Chopin, S., Tavtigian, S. V., Puisieux, A., Matar, C., & Herceg, Z. (2011) · Epigenetics · doi:10.4161/epi.6.4.14515 · Cited by 88
JNK Signaling in Stem Cell Self-Renewal and Differentiation
Semba, T., Sammons, R. M., Wang, X., Xie, X., Dalby, K. N., & Ueno, N. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072613 · Cited by 88
Kim, B., Yi, E. H., & Ye, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0795-8 · Cited by 87
Stevens, A. M., Miller, J. M., Munoz, J. O., Gaikwad, A. S., & Redell, M. S. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017007856 · Cited by 89
Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
Jia, D., Tan, Y., Liu, H., Ooi, S., Li, L., Wright, K. E., Bennett, S. A. L., Addison, C., & Wang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5819 · Cited by 86
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
Jin, X., Kim, S.-H., Jeon, H.-M., Beck, S. J., Sohn, Y.-W., Yin, J., Kim, J.-K., Lim, Y. C., Lee, J.-H., Kim, S.-H., et al. (2012) · Brain · doi:10.1093/brain/aws028 · Cited by 86
Erin, N., Podnos, A., Tanriover, G., Duymuş, Ö., Côté, É., Khatri, I. A., & Gorczynski, R. M. (2014) · Oncogene · doi:10.1038/onc.2014.317 · Cited by 86
Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
Louault, K., Bonneaud, T. L., Séveno, C., Gomez‐Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé‐Nion, S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0635-z · Cited by 85
HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
Nami, B., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050040 · Cited by 85
Kim, J. W., Márquez, C. P., Kostyrko, K., Koehne, A. L., Marini, K. D., Simpson, D. R., Lee, A. G., Leung, S. G., Sayles, L. C., Shrager, J. B., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0612-2 · Cited by 84
West, N. R., & Watson, P. H. (2010) · Oncogene · doi:10.1038/onc.2009.488 · Cited by 85
Gray, G. K., McFarland, B. C., Rowse, A. L., Gibson, S. A., & Benveniste, E. N. (2014) · Oncotarget · doi:10.18632/oncotarget.2248 · Cited by 84
Strong, A. L., Pei, D. T., Hurst, C. G., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2017) · Stem Cells International · doi:10.1155/2017/9216502 · Cited by 77
Novel roles of the unfolded protein response in the control of tumor development and aggressiveness
Dejeans, N., Barroso, K., Fernández-Zapico, M. E., Samali, A., & Chevet, É. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.007 · Cited by 84
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Ward, C., Meehan, J., Gray, M., Kunkler, I. H., Langdon, S. P., & Argyle, D. J. (2018) · Metabolites · doi:10.3390/metabo8010013 · Cited by 84
Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis
Papageorgis, P., Ozturk, S., Lambert, A. W., Neophytou, C. M., Tzatsos, A., Wong, C. K., Thiagalingam, S., & Constantinou, A. I. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0607-y · Cited by 83
Sharma, M., Bairy, I., Pai, K. M., Satyamoorthy, K., Prasad, S., Berkovitz, B. K. B., & Radhakrishnan, R. A. (2010) · Clinical Oral Investigations · doi:10.1007/s00784-010-0435-5 · Cited by 83
The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Zong, Z., Wei, Y., Ren, J., Zhang, L., & Zhou, F. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01363-1 · Cited by 82
Management of multicellular senescence and oxidative stress
Haines, D. D., Juhasz, B., & Tosaki, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12074 · Cited by 79
Interleukin-6 serves as a critical factor in various cancer progression and therapy
Mohamed, A. H., Ahmed, A. T., Abdulmonem, W. A., Bokov, D. O., Shafie, A., Al‐Hetty, H. R. A. K., Hsu, C., Alissa, M., Nazir, S., Jamali, M. C., et al. (2024) · Medical Oncology · doi:10.1007/s12032-024-02422-5 · Cited by 82
Intratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast Cancer
Zhang, M., Tsimelzon, A. I., Chang, C.-H., Fan, C., Wolff, A., Perou, C. M., Hilsenbeck, S. G., & Rosen, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1101 · Cited by 80
Novel insights into RB1 mutation
Yao, Y., Gu, X., Xu, X., Ge, S., & Jia, R. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215870 · Cited by 80
Oh, K., Ko, E., Kim, H. S., Park, A. K., Moon, H., Noh, D., & Lee, D. (2011) · Breast Cancer Research · doi:10.1186/bcr3034 · Cited by 79
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Balamurugan, K., Mendoza-Villanueva, D., Sharan, S., Summers, G. H., Dobrolecki, L. E., Lewis, M. T., & Sterneck, E. (2018) · Oncogene · doi:10.1038/s41388-018-0516-5 · Cited by 79
Heterogeneity and Plasticity of Breast Cancer Stem Cells
Sousa, B., Ribeiro, A. S., & Paredes, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_5 · Cited by 78
Yamada, S., OKUMURA, N., Wei, L., Fuchs, B. C., Fujii, T., Sugimoto, H., Nomoto, S., Takeda, S., Tanabe, K. K., & Kodera, Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3779-2 · Cited by 77
Wu, Y., Shan, B., Dai, J., Xia, Z., Cai, J., Chen, T., Lv, S., Feng, Y., Zheng, L., Wang, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29871 · Cited by 71
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis
Jung, I. H., Choi, J. H.-K., Chung, Y.-Y., Lim, G.-L., Park, Y. N., & Park, S. W. (2015) · Neoplasia · doi:10.1016/j.neo.2015.07.005 · Cited by 78
D'Anello, L., Sansone, P., Storci, G., Mitrugno, V., D’Uva, G., Chieco, P., & Bonafè, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-300 · Cited by 77
Self-citationPreclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
Rosean, T. R., Tompkins, V. S., Tricot, G. J. K., Holman, C., Olivier, A. K., Zhan, F., & Janz, S. (2014) · Immunologic Research · doi:10.1007/s12026-014-8528-x · Cited by 77
Stat3 Mediates Expression of Autotaxin in Breast Cancer
Azare, J., Doane, A., Leslie, K., Chang, Q., Berishaj, M., Nnoli, J., Mark, K., Al-Ahmadie, H., Gerald, W., Hassimi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027851 · Cited by 70
Weidle, U. H., Klostermann, S., Eggle, D., & Krüger, A. (2010) · PubMed · Cited by 76
Chang, Y.-C., Su, C.-Y., Chen, M.-H., Chen, W.-S., Chen, C.-L., & Hsiao, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0687-7 · Cited by 74
Luo, F., Xu, Y., Ling, M., Zhao, Y., Xu, W., Xiao, L., Jiang, R., Wang, B., Bian, Q., & Liu, Q. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.025 · Cited by 74
Chen, D., Liu, S., Ma, H., Liang, X., Ma, H., Yan, X., Bao, Y., Wei, J., & Liu, X. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0198-9 · Cited by 74
Cancer Stem Cell Epigenetics And Chemoresistance
Crea, F., Danesi, R., & Farrar, W. L. (2009) · Epigenomics · doi:10.2217/epi.09.4 · Cited by 74
Murayama, T., Nakaoku, T., Enari, M., Nishimura, T., Tominaga, K., Nakata, A., Tojo, A., Sugano, S., Kohno, T., & Gotoh, N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2135 · Cited by 74
Association of Cytokines and Chemokines in Pathogenesis of Breast Cancer
King, J., Mir, H., & Singh, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.003 · Cited by 74
Lee, J., Ryu, H. S., Hong, B. S., Lee, H., Lee, M., Park, I. A., Kim, J., Han, W., Noh, D., & Moon, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174126 · Cited by 74
Moving Breast Cancer Therapy up a Notch
Mollen, E., Ient, J., Tjan‐Heijnen, V. C. G., Boersma, L. J., Miele, L., Smidt, M. L., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00518 · Cited by 73
DiNatale, B. C., Schroeder, J. C., & Perdew, G. H. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20702 · Cited by 72
Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms
Poellinger, L., & Lendahl, U. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.013 · Cited by 72
Zhang, Z., Wang, H., Ikeda, S., Fahey, F. H., Bielenberg, D. R., Smits, P. J., & Hauschka, P. V. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090476 · Cited by 72
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
Debeb, B. G., Cohen, E. N., Boley, K. M., Freiter, E. M., Li, L., Robertson, F. M., Reuben, J. M., Cristofanilli, M., Buchholz, T. A., & Woodward, W. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2075-8 · Cited by 72
Azzam, D. J., Zhao, D., Sun, J., Minn, A. J., Ranganathan, P., Drews‐Elger, K., Han, X., Picon‐Ruiz, M., Gilbert, C. A., Wander, S. A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302558 · Cited by 72
Bocci, F., Jolly, M. K., George, J. T., Levine, H., & Onuchic, J. N. (2018) · Oncotarget · doi:10.18632/oncotarget.25692 · Cited by 72
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
The Role of Inflammation in Inflammatory Breast Cancer
Fouad, T. M., Kogawa, T., Reuben, J. M., & Ueno, N. T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_3 · Cited by 71
Papi, A., Guarnieri, T., Storci, G., Santini, D., Ceccarelli, C., Taffurelli, M., Carolis, S. D., Avenia, N., Sanguinetti, A., Sidoni, A., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2011.207 · Cited by 71
Self-citationXie, W., Huang, Y., Xie, W., Guo, A., & Wu, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010850 · Cited by 71
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
Oren, O., & Smith, B. D. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9691-3 · Cited by 71
Cytokines in milk and the role of TGF-beta
Brenmoehl, J., Ohde, D., Wirthgen, E., & Hoeflich, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.01.006 · Cited by 71
Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes
McQuerry, J. A., Chang, J. T., Bowtell, D. D. L., Cohen, A. L., & Bild, A. H. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1587-4 · Cited by 71
Noncoding RNAs: the shot callers in tumor immune escape
Liu, L., Wang, Q., Qiu, Z., Kang, Y., Liu, J., Ning, S., Yin, Y., Pang, D., & Xu, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0194-y · Cited by 70
Inflammation linking EMT and cancer stem cells
Zhou, C., Liu, J., Tang, Y., & Liang, X. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.005 · Cited by 71
Yun, U. J., Park, S. E., Jo, Y. S., Kim, J., & Shin, D. Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.003 · Cited by 69
“[20–23].”
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
Alam, M., Rajabi, H. N., Ahmad, R., Jin, C., & Kufe, D. W. (2014) · Oncotarget · doi:10.18632/oncotarget.1848 · Cited by 69
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
Baram, T., Rubinstein-Achiasaf, L., Ben-Yaakov, H., & Ben‐Baruch, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.614468 · Cited by 69
Yuan, Q., Chen, Y., Li, X., Zhang, Z., & Chu, H. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.12.005 · Cited by 69
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.